{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:44Z","timestamp":1786119104425,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11999-009-0725-x","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T10:52:23Z","timestamp":1233831143000},"page":"1921-1926","source":"Crossref","is-referenced-by-count":71,"title":["Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy"],"prefix":"10.1097","volume":"467","author":[{"given":"Arkan S.","family":"Sayed-Noor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran O.","family":"Sj\u00f6d\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20210317","first-page":"suppl","article-title":"A 5 year randomized trial of the long-term efficacy and safety of alendronate.","volume":"10","author":"Black","year":"2004","journal-title":"J Bone Mineral Res"},{"key":"R2-37-20210317","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"R3-37-20210317","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11914-004-0011-5","article-title":"Intravenous bisphosphonate therapy for osteoporosis: where do we stand?","volume":"2","author":"Bone","year":"2004","journal-title":"Curr Osteoporos Rep"},{"key":"R4-37-20210317","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1302\/0301-620X.52B3.509","article-title":"Subtrochanteric fractures in osteomalacia.","volume":"52","author":"Chalmers","year":"1970","journal-title":"J Bone Joint Surg Br"},{"key":"R5-37-20210317","first-page":"485","article-title":"Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate.","volume":"13","author":"Cheung","year":"2007","journal-title":"Hong Kong Med J"},{"key":"R6-37-20210317","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"R7-37-20210317","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1098\/rstb.1984.0042","article-title":"Effects of differences in mineralization on the mechanical properties of bone.","volume":"304","author":"Currey","year":"1984","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R8-37-20210317","first-page":"455","article-title":"Hip pain in a case of hypophosphatemic osteomalacia.","volume":"32","author":"Esterberg","year":"2003","journal-title":"Am J Orthop"},{"key":"R9-37-20210317","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: mechanisms of action.","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr Rev"},{"key":"R10-37-20210317","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0883-5403(99)90014-1","article-title":"Lateral insufficiency fractures of the femur caused by osteopenia and varus angulation: a complication of total hip arthroplasty.","volume":"14","author":"Gill","year":"1999","journal-title":"J Arthroplasty"},{"key":"R11-37-20210317","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"R12-37-20210317","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2005-869481","article-title":"Prevention of postmenopausal bone loss and treatment of osteoporosis.","volume":"23","author":"Kleerekoper","year":"2005","journal-title":"Semin Reprod Med"},{"key":"R13-37-20210317","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1297-319X(03)00143-X","article-title":"Subtrochanteric fracture managed by intramedullary nail in a patient with pycnodysostosis.","volume":"71","author":"Kundu","year":"2004","journal-title":"Joint Bone Spine"},{"key":"R14-37-20210317","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"key":"R15-37-20210317","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.","volume":"358","author":"Lenart","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-37-20210317","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.injury.2007.02.048","article-title":"Epidemiology of periprosthetic femur fracture around total hip arthroplasty.","volume":"38","author":"Lindahl","year":"2007","journal-title":"Injury"},{"key":"R17-37-20210317","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0020-1383(01)00134-6","article-title":"Pathological fractures in primary hyperparathyroidism: a case report highlighting diagnostic difficulties.","volume":"33","author":"Morgan","year":"2002","journal-title":"Injury"},{"key":"R18-37-20210317","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use.","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"R19-37-20210317","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy.","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-37-20210317","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates. Editorial.","volume":"90","author":"Ott","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-37-20210317","first-page":"1","article-title":"The significance of the structural principles of the locomotor apparatus to resist the forces applied on long bones.","volume":"114","author":"Pauwels","year":"1948","journal-title":"Anat Embryol"},{"key":"R22-37-20210317","first-page":"247","article-title":"Pycnodysostosis presenting with bilateral subtrochanteric fractures: case report.","volume":"117","author":"Roth","year":"1976","journal-title":"Clin Orthop Relat Res"},{"key":"R23-37-20210317","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17453670710015580","article-title":"Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy: a case report.","volume":"79","author":"Sayed-Noor","year":"2008","journal-title":"Acta Orthop"},{"key":"R24-37-20210317","first-page":"31","article-title":"Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate.","volume":"61","author":"Schneider","year":"2006","journal-title":"Geriatrics"},{"key":"R25-37-20210317","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00003086-199012000-00032","article-title":"Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis.","volume":"261","author":"Schnitzler","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"R26-37-20210317","first-page":"3109","article-title":"Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women.","volume":"85","author":"Tonino","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Orthopaedics & Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1007\/s11999-009-0725-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:33:49Z","timestamp":1786037629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003086-200907000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1007\/s11999-009-0725-x","relation":{},"ISSN":["0009-921X"],"issn-type":[{"value":"0009-921X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}